| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.10428 |
| P698 | PubMed publication ID | 12209513 |
| P2093 | author name string | Michael Tanzer | |
| John Antoniou | |||
| A Robin Poole | |||
| William Wu | |||
| Isabelle Pidoux | |||
| R Clark Billinghurst | |||
| David Zukor | |||
| P433 | issue | 8 | |
| P921 | main subject | osteoarthritis | Q62736 |
| denaturation | Q273186 | ||
| P304 | page(s) | 2087-2094 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13 | |
| P478 | volume | 46 |
| Q30318560 | 17β-estradiol reduces expression of MMP-1, -3, and -13 in human primary articular chondrocytes from female patients cultured in a three dimensional alginate system |
| Q80773402 | A sensitive, rapid and specific technique for the detection of collagenase using zymography |
| Q37958708 | Action mechanisms of complementary and alternative medicine therapies for rheumatoid arthritis |
| Q34062933 | Age-related changes in the musculoskeletal system and the development of osteoarthritis |
| Q37268683 | Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix |
| Q35578043 | Aging or osteoarthritis: which is the problem? |
| Q48316070 | Amniotic mesenchymal stem cells mitigate osteoarthritis progression in a synovial macrophage-mediated in vitro explant coculture model |
| Q37609322 | An in vitro model for the pathological degradation of articular cartilage in osteoarthritis |
| Q33923238 | Anabolic and catabolic responses of human articular chondrocytes to varying oxygen percentages |
| Q39906208 | Anticytokine therapy for osteoarthritis: evidence to date |
| Q99609481 | Arthritis and the role of endogenous glucocorticoids |
| Q51767972 | Articular Cartilage Aging-Potential Regenerative Capacities of Cell Manipulation and Stem Cell Therapy. |
| Q35571353 | Articular cartilage zonal differentiation via 3D Second-Harmonic Generation imaging microscopy |
| Q42286696 | Assessment of apoptosis and MMP-1, MMP-3 and TIMP-2 expression in tibial hyaline cartilage after viable medial meniscus transplantation in the rabbit |
| Q35578072 | Biochemical/immunochemical biomarkers of osteoarthritis: utility for prediction of incident or progressive osteoarthritis |
| Q36245833 | Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes |
| Q37270714 | Cartilage homeostasis in health and rheumatic diseases |
| Q37721188 | Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue |
| Q38960505 | Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk |
| Q36111296 | Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis |
| Q38526059 | Chondropenia: current concept review |
| Q35638306 | CleavPredict: A Platform for Reasoning about Matrix Metalloproteinases Proteolytic Events |
| Q37331102 | Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism |
| Q37397954 | Deformation-dependent enzyme mechanokinetic cleavage of type I collagen |
| Q38802370 | Developmental mechanisms in articular cartilage degradation in osteoarthritis |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q38836892 | Effects of dendritic polyglycerol sulfate on articular chondrocytes |
| Q34978060 | Evaluating Osteoarthritic Chondrocytes through a Novel 3-Dimensional In Vitro System for Cartilage Tissue Engineering and Regeneration |
| Q41531870 | Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis |
| Q47897144 | Extracellular Distribution of Collagen II and Perifibrillar Adapter Proteins in Healthy and Osteoarthritic Human Knee Joint Cartilage |
| Q30433820 | Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway |
| Q51763411 | Gene-expression changes in knee-joint tissues with aging and menopause: implications for the joint as an organ. |
| Q64951555 | High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. |
| Q34153150 | High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes |
| Q33325058 | High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate |
| Q47191620 | Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes. |
| Q64990098 | Identify CRNDE and LINC00152 as the key lncRNAs in age-related degeneration of articular cartilage through comprehensive and integrative analysis. |
| Q50034063 | Impact of Arginine to Cysteine Mutations in Collagen II on Protein Secretion and Cell Survival |
| Q58390026 | Impairment of the collagenase-3 endocytotic receptor system in cells from patients with osteoarthritis |
| Q55063229 | In vitro study on role of σB protein in avian reovirus pathogenesis. |
| Q34693817 | Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli |
| Q36245974 | Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage |
| Q55225273 | Laboratory Standards in Diagnosis and Therapy Monitoring of Rheumatoid Arthritis. |
| Q35803228 | Lentivirus-induced knockdown of LRP1 induces osteoarthritic-like effects and increases susceptibility to apoptosis in chondrocytes via the nuclear factor-κB pathway |
| Q50213518 | Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring Arthroplasty. |
| Q37566392 | Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury |
| Q33706862 | Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. |
| Q35852281 | Matrix metalloproteinases as modulators of inflammation and innate immunity |
| Q51155840 | Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression. |
| Q33992822 | NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments |
| Q59942491 | Novel model for the induction of postnatal murine hip deformity |
| Q43245111 | Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants |
| Q39866174 | Osteoblasts derived from osteophytes produce interleukin-6, interleukin-8, and matrix metalloproteinase-13 in osteoarthritis |
| Q41602372 | PKR activation causes inflammation and MMP-13 secretion in human degenerated articular chondrocytes |
| Q38104445 | Pathogenesis of epiphyseal osteochondrosis |
| Q28581964 | Physiological loading of joints prevents cartilage degradation through CITED2 |
| Q33608536 | Progress in matrix metalloproteinase research |
| Q50872022 | Protective effects of Nebivolol against interleukin-1β (IL-1β)-induced type II collagen destruction mediated by matrix metalloproteinase-13 (MMP-13). |
| Q64085257 | Pyrroloquinoline quinone prevents knee osteoarthritis by inhibiting oxidative stress and chondrocyte senescence |
| Q37078072 | Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair? |
| Q35783187 | RelA is required for IL-1beta stimulation of Matrix Metalloproteinase-1 expression in chondrocytes |
| Q37609032 | Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. |
| Q54959971 | The Value of Phenotypes in Knee Osteoarthritis Research. |
| Q26863325 | The age-related changes in cartilage and osteoarthritis |
| Q24797661 | The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytes |
| Q34963140 | Type II collagen degradation and its regulation in articular cartilage in osteoarthritis |
| Q41456227 | Viability and Tissue Quality of Cartilage Flaps From Patients With Femoroacetabular Hip Impingement: A Matched-Control Comparison |
| Q35117279 | What type of cartilage repair are we attempting to attain? |
| Q37289674 | Why Do Osteochondral Allografts Survive? Comparative Analysis of Cartilage Biochemical Properties Unveils a Molecular Basis for Durability |
| Q33636855 | Why is osteoarthritis an age-related disease? |
Search more.